September 23, 2020

Inovio Pharmaceuticals to Participate in BIO Vaccine Panel and Present at Marcum Investor Conference

0
0



Pin It

Inovio Pharmaceuticals, Inc. (nyse mkt:INO) announced today that Dr. Niranjan Sardesai, COO, will participate on a panel of senior vaccine experts at the 2012 BIO International Convention,the largest global event for the biotechnology industry. Dr. J. Joseph Kim, President and CEO, will present an overview of the company at the Marcum Microcap Conference, which is designed for investors interested in micro-cap companies.

Marcum LLP is one of the largest independent public accounting and advisory services firms in the nation. The firm has full service offices strategically located in 23 offices throughout the US as well as Grand Cayman, China and Hong Kong. Marcum is a member of the Marcum Group, the gateway to a group of organizations that provide a variety of professional services.

2012 BIO International Convention June 18-21, 2012Boston Convention & Exhibition Center, MA

Panel Leveraging New Development Paradigms to Address Infectious Diseases in the 21st Century Session ID: 1201Tuesday, June 1910:00 AM – 11:30 a.m. ET

Topic The “one bug, one vaccine” paradigm worked for years and eradicated some major diseases. Today’s bugs are pathogens that either change rapidly or have many serotypes–and they command innovation throughout the vaccine value chain. The panel will discuss 21st century needs and the innovations necessary for new vaccines.

Participants

Moderator: Stanley Plotkin Consultant in Vaccinology, Sanofi Pasteur

Jeffrey AlmondVice President, Discovery Research and External R&D, Sanofi Pasteur

Anthony Ford-HutchinsonIndependent Consultant, Ford-Hutchinson Consulting Ltd. Retired Merck Senior Vice President, Vaccines Research and Development

Christian W. MandlVP, Head of US Research, Novartis Vaccine & Diagnostics, Inc. and Global Head for all viral vaccine research projects

Regina Rabinovich Director, Enteric & Diarrheal Diseases and Pneumonia & Interim Director Malaria, Global Health Program, Bill & Melinda Gates Foundation

Niranjan Sardesai Chief Operating Officer, Inovio Pharmaceuticals

Marcum Microcap Investor ConferenceJune 20, 201245 East 45th Street, The Roosevelt HotelNew York City, New York

Inovio PresentationWednesday, June 20 12:00 – 12:30 p.m. ETJ. Joseph Kim, PhD, President and CEO

A live and archived webcast of the presentation will be accessible on Inovio’s website at http://www.inovio.com

Marcum Microcap Conference. The Marcum MicroCap conference is designed for investors interested in the micro-cap arena. The event is free to attend for qualified investors and the company will make a formal presentation and be available for one-on-ones.

CCG Investor RelationsCCG is a leading global investor relations and strategic communications consulting firm providing a complete range of investor communications, counseling, and IT and data solutions through its global network to over 100 clients across multiple capital markets. The agency has offices in Los Angeles, New York, Beijing, Shanghai, Hong Kong, London and Tel Aviv.

Print Friendly, PDF & Email

Speak Your Mind

*